CA Stock MarketDetailed Quotes

DMT Small Pharma Inc

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)

Small Pharma Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)May 31, 2023
(FY)Feb 28, 2023
(Q4)Feb 28, 2023
(Q3)Nov 30, 2022
(Q2)Aug 31, 2022
(Q1)May 31, 2022
(FY)Feb 28, 2022
(Q4)Feb 28, 2022
(Q3)Nov 30, 2021
(Q2)Aug 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-0.56%5.75M
37.59%24.7M
-22.04%4.27M
54.50%7.13M
64.71%7.46M
73.49%5.78M
215.03%17.95M
140.16%5.47M
213.42%4.62M
282.91%4.53M
Selling and administrative expenses
-14.01%2.73M
5.12%10.99M
-79.43%686.89K
18.59%3M
78.01%4.1M
15.44%3.18M
203.97%10.45M
94.27%3.34M
301.05%2.53M
335.06%2.3M
-General and administrative expense
-14.01%2.73M
5.12%10.99M
-79.43%686.89K
18.59%3M
78.01%4.1M
39.72%3.18M
203.97%10.45M
94.27%3.34M
301.05%2.53M
335.06%2.3M
Research and development costs
19.41%2.49M
135.75%11.38M
90.45%2.9M
243.11%3.62M
54.00%2.72M
334.02%2.09M
151.42%4.83M
361.37%1.52M
37.93%1.06M
183.11%1.77M
Depreciation amortization depletion
1,404.15%85.53K
136.46%48.44K
480.36%31.36K
9.88%5.74K
14.23%5.65K
15.78%5.69K
233.54%20.49K
31.24%5.4K
158.21%5.22K
--4.94K
-Depreciation and amortization
1,404.15%85.53K
136.46%48.44K
480.36%31.36K
9.88%5.74K
14.23%5.65K
15.78%5.69K
233.54%20.49K
31.24%5.4K
158.21%5.22K
--4.94K
Other operating expenses
-14.33%431.04K
-13.91%2.28M
7.17%646.21K
-50.99%502.3K
39.35%630.5K
462.81%503.16K
694.68%2.65M
168.26%602.96K
1,280.36%1.02M
1,465.53%452.47K
Operating profit
0.56%-5.75M
-37.59%-24.7M
22.04%-4.27M
-54.50%-7.13M
-64.71%-7.46M
-73.49%-5.78M
-219.38%-17.95M
-140.19%-5.47M
-213.42%-4.62M
-294.24%-4.53M
Net non-operating interest income (expenses)
2,596.64%105.82K
104.85%21.02K
-68.48%10.31K
2.56K
12,163.89%4.34K
100.84%3.92K
10.55%-433.73K
108.20%32.72K
0
99.65%-36
Non-operating interest income
2,790.75%113.43K
--21.02K
--10.31K
--2.56K
--4.34K
--3.92K
----
----
--0
----
Non-operating interest expense
--7.62K
--0
--0
--0
--0
--0
-10.55%433.73K
-108.20%-32.72K
--0
-99.65%36
Other net income (expenses)
45.74%-4.31K
99.09%-41.34K
54.14%-2.79K
-85.86%-28.13K
32.00%-2.53K
99.82%-7.94K
-391.50%-4.53M
99.28%-6.08K
74.84%-15.14K
74.45%-3.73K
Gain on sale of security
45.74%-4.31K
98.05%-41.34K
54.14%-2.79K
-85.86%-28.13K
32.00%-2.53K
99.62%-7.94K
-129.24%-2.12M
99.28%-6.08K
74.84%-15.14K
74.45%-3.73K
Special income (charges)
----
--0
--0
--0
--0
----
---2.42M
--0
--0
--0
-Less:Restructuring and mergern&acquisition
----
--0
--0
--0
--0
----
--2.42M
--0
--0
--0
Income before tax
2.39%-5.64M
-7.86%-24.72M
21.80%-4.26M
-54.55%-7.16M
-64.53%-7.46M
30.44%-5.78M
-226.11%-22.92M
-54.48%-5.44M
-187.83%-4.63M
-286.24%-4.53M
Income tax
0
-187.74%-1.89M
-187.74%-1.89M
0
0
0
-9,845.14%-655.17K
-3,448,342.11%-655.17K
0
0
Earnings from equity interest net of tax
Net income
2.39%-5.64M
-2.56%-22.84M
50.46%-2.37M
-54.55%-7.16M
-64.53%-7.46M
30.44%-5.78M
-216.49%-22.27M
-35.89%-4.79M
-186.64%-4.63M
-286.24%-4.53M
Net income continuous operations
2.39%-5.64M
-2.56%-22.84M
50.46%-2.37M
-54.55%-7.16M
-64.53%-7.46M
30.44%-5.78M
-216.49%-22.27M
-35.89%-4.79M
-186.64%-4.63M
-286.24%-4.53M
Noncontrolling interests
Net income attributable to the company
2.39%-5.64M
-2.56%-22.84M
50.46%-2.37M
-54.55%-7.16M
-64.53%-7.46M
30.44%-5.78M
-216.49%-22.27M
-35.89%-4.79M
-186.64%-4.63M
-286.24%-4.53M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
2.39%-5.64M
-2.56%-22.84M
50.46%-2.37M
-54.55%-7.16M
-64.53%-7.46M
30.44%-5.78M
-216.49%-22.27M
-35.89%-4.79M
-186.64%-4.63M
-286.24%-4.53M
Diluted earnings per share
0.00%-0.02
0.00%-0.07
0.00%-0.01
0.00%-0.02
-100.00%-0.02
33.33%-0.02
-215.22%-0.07
10.12%-0.01
-292.23%-0.02
-169.98%-0.01
Basic earnings per share
0.00%-0.02
0.00%-0.07
0.00%-0.01
0.00%-0.02
-100.00%-0.02
33.33%-0.02
-215.22%-0.07
10.12%-0.01
-292.23%-0.02
-169.98%-0.01
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)May 31, 2023(FY)Feb 28, 2023(Q4)Feb 28, 2023(Q3)Nov 30, 2022(Q2)Aug 31, 2022(Q1)May 31, 2022(FY)Feb 28, 2022(Q4)Feb 28, 2022(Q3)Nov 30, 2021(Q2)Aug 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -0.56%5.75M37.59%24.7M-22.04%4.27M54.50%7.13M64.71%7.46M73.49%5.78M215.03%17.95M140.16%5.47M213.42%4.62M282.91%4.53M
Selling and administrative expenses -14.01%2.73M5.12%10.99M-79.43%686.89K18.59%3M78.01%4.1M15.44%3.18M203.97%10.45M94.27%3.34M301.05%2.53M335.06%2.3M
-General and administrative expense -14.01%2.73M5.12%10.99M-79.43%686.89K18.59%3M78.01%4.1M39.72%3.18M203.97%10.45M94.27%3.34M301.05%2.53M335.06%2.3M
Research and development costs 19.41%2.49M135.75%11.38M90.45%2.9M243.11%3.62M54.00%2.72M334.02%2.09M151.42%4.83M361.37%1.52M37.93%1.06M183.11%1.77M
Depreciation amortization depletion 1,404.15%85.53K136.46%48.44K480.36%31.36K9.88%5.74K14.23%5.65K15.78%5.69K233.54%20.49K31.24%5.4K158.21%5.22K--4.94K
-Depreciation and amortization 1,404.15%85.53K136.46%48.44K480.36%31.36K9.88%5.74K14.23%5.65K15.78%5.69K233.54%20.49K31.24%5.4K158.21%5.22K--4.94K
Other operating expenses -14.33%431.04K-13.91%2.28M7.17%646.21K-50.99%502.3K39.35%630.5K462.81%503.16K694.68%2.65M168.26%602.96K1,280.36%1.02M1,465.53%452.47K
Operating profit 0.56%-5.75M-37.59%-24.7M22.04%-4.27M-54.50%-7.13M-64.71%-7.46M-73.49%-5.78M-219.38%-17.95M-140.19%-5.47M-213.42%-4.62M-294.24%-4.53M
Net non-operating interest income (expenses) 2,596.64%105.82K104.85%21.02K-68.48%10.31K2.56K12,163.89%4.34K100.84%3.92K10.55%-433.73K108.20%32.72K099.65%-36
Non-operating interest income 2,790.75%113.43K--21.02K--10.31K--2.56K--4.34K--3.92K----------0----
Non-operating interest expense --7.62K--0--0--0--0--0-10.55%433.73K-108.20%-32.72K--0-99.65%36
Other net income (expenses) 45.74%-4.31K99.09%-41.34K54.14%-2.79K-85.86%-28.13K32.00%-2.53K99.82%-7.94K-391.50%-4.53M99.28%-6.08K74.84%-15.14K74.45%-3.73K
Gain on sale of security 45.74%-4.31K98.05%-41.34K54.14%-2.79K-85.86%-28.13K32.00%-2.53K99.62%-7.94K-129.24%-2.12M99.28%-6.08K74.84%-15.14K74.45%-3.73K
Special income (charges) ------0--0--0--0-------2.42M--0--0--0
-Less:Restructuring and mergern&acquisition ------0--0--0--0------2.42M--0--0--0
Income before tax 2.39%-5.64M-7.86%-24.72M21.80%-4.26M-54.55%-7.16M-64.53%-7.46M30.44%-5.78M-226.11%-22.92M-54.48%-5.44M-187.83%-4.63M-286.24%-4.53M
Income tax 0-187.74%-1.89M-187.74%-1.89M000-9,845.14%-655.17K-3,448,342.11%-655.17K00
Earnings from equity interest net of tax
Net income 2.39%-5.64M-2.56%-22.84M50.46%-2.37M-54.55%-7.16M-64.53%-7.46M30.44%-5.78M-216.49%-22.27M-35.89%-4.79M-186.64%-4.63M-286.24%-4.53M
Net income continuous operations 2.39%-5.64M-2.56%-22.84M50.46%-2.37M-54.55%-7.16M-64.53%-7.46M30.44%-5.78M-216.49%-22.27M-35.89%-4.79M-186.64%-4.63M-286.24%-4.53M
Noncontrolling interests
Net income attributable to the company 2.39%-5.64M-2.56%-22.84M50.46%-2.37M-54.55%-7.16M-64.53%-7.46M30.44%-5.78M-216.49%-22.27M-35.89%-4.79M-186.64%-4.63M-286.24%-4.53M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 2.39%-5.64M-2.56%-22.84M50.46%-2.37M-54.55%-7.16M-64.53%-7.46M30.44%-5.78M-216.49%-22.27M-35.89%-4.79M-186.64%-4.63M-286.24%-4.53M
Diluted earnings per share 0.00%-0.020.00%-0.070.00%-0.010.00%-0.02-100.00%-0.0233.33%-0.02-215.22%-0.0710.12%-0.01-292.23%-0.02-169.98%-0.01
Basic earnings per share 0.00%-0.020.00%-0.070.00%-0.010.00%-0.02-100.00%-0.0233.33%-0.02-215.22%-0.0710.12%-0.01-292.23%-0.02-169.98%-0.01
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg